These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19740322)

  • 1. Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-gamma secretion by antigen-specific CD8 T cells.
    Muthumani G; Laddy DJ; Sundaram SG; Fagone P; Shedlock DJ; Kannan S; Wu L; Chung CW; Lankaraman KM; Burns J; Muthumani K; Weiner DB
    Immunology; 2009 Sep; 128(1 Suppl):e612-20. PubMed ID: 19740322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in T helper 1-related immune responses in BALB/c mice immunized with an HIV-1 gag plasmid combined with a chimeric plasmid encoding interleukin-18 and flagellin.
    Chen YL; Chen YS; Hung YC; Liu PJ; Tasi HY; Ni WF; Hseuh PT; Lin HH
    Microbiol Immunol; 2015 Aug; 59(8):483-94. PubMed ID: 26094825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.
    Kanagavelu SK; Snarsky V; Termini JM; Gupta S; Barzee S; Wright JA; Khan WN; Kornbluth RS; Stone GW
    Vaccine; 2012 Jan; 30(4):691-702. PubMed ID: 22146759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
    Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M
    Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines.
    Xu R; Megati S; Roopchand V; Luckay A; Masood A; Garcia-Hand D; Rosati M; Weiner DB; Felber BK; Pavlakis GN; Sidhu MK; Eldridge JH; Egan MA
    Vaccine; 2008 Sep; 26(37):4819-29. PubMed ID: 18657584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced immune response against HIV-1 induced by a heterologous DNA prime-adenovirus boost vaccination using mannosylated polyethyleneimine as DNA vaccine adjuvant.
    Li M; Jiang Y; Xu C; Zhang Z; Sun X
    Int J Nanomedicine; 2013; 8():1843-54. PubMed ID: 23690682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophilin A as a potential genetic adjuvant to improve HIV-1 Gag DNA vaccine immunogenicity by eliciting broad and long-term Gag-specific cellular immunity in mice.
    Hou J; Zhang Q; Liu Z; Wang S; Li D; Liu C; Liu Y; Shao Y
    Hum Vaccin Immunother; 2016; 12(2):545-53. PubMed ID: 26305669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.
    Li W; Li S; Hu Y; Tang B; Cui L; He W
    Vaccine; 2008 Jun; 26(26):3282-90. PubMed ID: 18472194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus.
    Khattar SK; Palaniyandi S; Samal S; LaBranche CC; Montefiori DC; Zhu X; Samal SK
    Hum Vaccin Immunother; 2015; 11(2):504-15. PubMed ID: 25695657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the potency of DNA vaccine encoding HIV-1 Nef antigen using two endogenous adjuvants in mouse model.
    Jafarzade BS; Sadat SM; Yaghobi R; Bolhassani A
    Bratisl Lek Listy; 2017; 118(9):564-569. PubMed ID: 29061065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.
    Kutzler MA; Robinson TM; Chattergoon MA; Choo DK; Choo AY; Choe PY; Ramanathan MP; Parkinson R; Kudchodkar S; Tamura Y; Sidhu M; Roopchand V; Kim JJ; Pavlakis GN; Felber BK; Waldmann TA; Boyer JD; Weiner DB
    J Immunol; 2005 Jul; 175(1):112-23. PubMed ID: 15972637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune Adjuvant.
    Gómez CE; Perdiguero B; Falqui M; Marín MQ; Bécares M; Sorzano CÓS; García-Arriaza J; Esteban M; Guerra S
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques.
    Kraynyak KA; Kutzler MA; Cisper NJ; Khan AS; Draghia-Akli R; Sardesal NY; Lewis MG; Yan J; Weiner DB
    Vaccine; 2010 Feb; 28(8):1942-51. PubMed ID: 20188250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/SIV DNA vaccine combined with protein in a co-immunization protocol elicits highest humoral responses to envelope in mice and macaques.
    Li J; Valentin A; Kulkarni V; Rosati M; Beach RK; Alicea C; Hannaman D; Reed SG; Felber BK; Pavlakis GN
    Vaccine; 2013 Aug; 31(36):3747-55. PubMed ID: 23624057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery.
    Bolesta E; Kowalczyk A; Wierzbicki A; Eppolito C; Kaneko Y; Takiguchi M; Stamatatos L; Shrikant PA; Kozbor D
    J Immunol; 2006 Jul; 177(1):177-91. PubMed ID: 16785513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8
    Li SS; Kochar NK; Elizaga M; Hay CM; Wilson GJ; Cohen KW; De Rosa SC; Xu R; Ota-Setlik A; Morris D; Finak G; Allen M; Tieu HV; Frank I; Sobieszczyk ME; Hannaman D; Gottardo R; Gilbert PB; Tomaras GD; Corey L; Clarke DK; Egan MA; Eldridge JH; McElrath MJ; Frahm N;
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28931520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
    Gómez CE; Nájera JL; Jiménez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette MJ; Pantaleo G; Wolf H; Liljeström P; Wagner R; Esteban M
    Vaccine; 2007 Mar; 25(11):1969-92. PubMed ID: 17224219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.